N-(4-methylphenyl)methanesulfonamide, 95.0%, 250mg

GlcNAc beta(1-2)Man-alpha-ethylazide>98.0%(HPLC)100mg

Ensemble de polarisation. L'analyseur de diamètre 18 mm est placé dans l'oculaire, le polariseur de diamètre 32 mm est placé dans le porte filtre

1-(Anthracen-9-yl)-N-methylmethanamine, 95.0%, 5g

1H-PYRROLO[3,2-B]PYRIDINE-2-CARBOXYLIC ACID, 7-CHLORO-3-METHYL-, ETHYL ESTER, 95.0%, 250mg

4-ethyl-2-methyl-4H-furo[3,2-b]pyrrole-5-carboxylic acid, 95.0%, 2g

5-(2-Chlorophenyl)cyclohexane-1,3-dione, 97.0%, 250mg

Ethyl 7-chloro-4-hydroxy-8-methylquinoline-3-carboxylate, 95.0%, 250mg

(R)-6-((1R,3aS,7aR,E)-4-((Z)-2-((3S,5R)-3,5-bis(tert-butyldimethylsilyloxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)-2-methylheptan-2-ol, 98%, 50mg

Tetrahydrofuran-2-carboximidamide hydrochloride, 97.0%, 1g

2-Methoxy-3-nitropyridin-4-amine, 95.0%, 500mg

4-Bromo-2,5-dichlorophenol, 95.0%, 500g

N-(4-chlorobenzyl)-2-butanamine hydrochloride, 95.0%, 5g